Clinical trial
Immune Abnormalities in Sporadic Inclusion Body Myositis
NCT00030212 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00030212 |
|---|---|
| Title | Immune Abnormalities in Sporadic Inclusion Body Myositis |
| Official title | Study of Immune Dysregulation in Patients With Sporadic Inclusion Body Myositis (s-IBM) |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Sporadic, Inclusion Body, Myositis |
| Enrollment | 80 |
| Start date | Feb 4, 2002 |
| Completion | Dec 10, 2007 |
| First posted | Feb 8, 2002 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: